SCHOTT Pharma AG & Co. KGaA Analysts estimates
Consensus as of: 2025-05-21

KPI[EUR m]Q3 2024FY 2024Q3 2025 EFY 2025 EFY 2026 EFY 2027 E
RevenueNumber of Estimates5141414
RevenueHighest278.91,048.11,173.61,320.0
RevenueConsensus (Mean)253.5957.1265.81,018.41,136.21,262.5
RevenueMedian262.61,015.81,135.91,260.2
RevenueLowest260.0998.61,080.81,212.6
Organic revenue growth (in %)Number of Estimates5988
Organic revenue growth (in %)Highest11.09.513.712.5
Organic revenue growth (in %)Consensus (Mean)21.012.06.87.910.810.6
Organic revenue growth (in %)Median5.97.910.510.1
Organic revenue growth (in %)Lowest5.06.58.29.6
EBITDANumber of Estimates5141313
EBITDAHighest79.0285.0342.0401.0
EBITDAConsensus (Mean)74.4257.675.2275.8324.3372.6
EBITDAMedian74.8274.7326.4372.5
EBITDALowest72.0269.0304.4338.8
EBITDA Margin (in %)Number of Estimates5141313
EBITDA Margin (in %)Highest28.827.629.631.3
EBITDA Margin (in %)Consensus (Mean)29.326.928.327.128.529.5
EBITDA Margin (in %)Median28.427.028.629.5
EBITDA Margin (in %)Lowest27.426.627.227.5
EBITNumber of Estimates4131313
EBITHighest79.0212.0259.3316.1
EBITConsensus (Mean)58.0192.658.6200.1238.8275.8
EBITMedian52.0199.1239.4273.9
EBITLowest51.6182.8212.0244.4
Net incomeNumber of Estimates4141414
Net incomeHighest62.9162.6200.3244.0
Net incomeConsensus (Mean)46.3149.746.5154.0185.3216.0
Net incomeMedian41.9153.0184.1215.5
Net incomeLowest39.2150.2170.6199.1
EPSNumber of Estimates4141414
EPSHighest0.421.081.331.62
EPSConsensus (Mean)0.310.990.311.021.231.44
EPSMedian0.281.021.221.43
EPSLowest0.261.001.131.32
DPSNumber of Estimates-131313
DPSHighest-0.200.240.28
DPSConsensus (Mean)-0.16-0.160.200.23
DPSMedian-0.160.200.22
DPSLowest-0.150.170.20
CapexNumber of Estimates-121212
CapexHighest--150.0-145.3-145.0
CapexConsensus (Mean)-24.2-145.3--166.3-170.1-170.8
CapexMedian--172.9-168.9-166.9
CapexLowest--185.0-211.5-233.8
FCFNumber of Estimates-121212
FCFHighest-73.087.0152.1
FCFConsensus (Mean)33.779.0-40.859.8103.5
FCFMedian-41.575.4107.6
FCFLowest--3.3-34.511.3
DCS, RevenueNumber of Estimates5999
DCS, RevenueHighest142.9563.4615.1676.1
DCS, RevenueConsensus (Mean)137.3518.7138.8545.1583.3624.6
DCS, RevenueMedian138.6542.6582.0623.1
DCS, RevenueLowest136.3534.1560.8588.8
DCS, EBITDANumber of Estimates5999
DCS, EBITDAHighest33.3124.2142.5155.8
DCS, EBITDAConsensus (Mean)29.8101.330.4114.8128.7141.8
DCS, EBITDAMedian31.7115.0132.6145.0
DCS, EBITDALowest24.597.1110.3120.7
DCS, EBITDA Margin (in %)Number of Estimates5999
DCS, EBITDA Margin (in %)Highest24.022.924.725.0
DCS, EBITDA Margin (in %)Consensus (Mean)21.719.521.921.122.122.7
DCS, EBITDA Margin (in %)Median23.221.022.222.9
DCS, EBITDA Margin (in %)Lowest17.917.919.020.4
DDS, RevenueNumber of Estimates5999
DDS, RevenueHighest136.1505.5594.7684.1
DDS, RevenueConsensus (Mean)116.4438.7127.0471.7543.6621.7
DDS, RevenueMedian126.4465.1545.0625.0
DDS, RevenueLowest120.6460.0503.9562.2
DDS, EBITDANumber of Estimates5999
DDS, EBITDAHighest50.4184.2219.6256.1
DDS, EBITDAConsensus (Mean)43.2166.445.5164.5194.9227.2
DDS, EBITDAMedian43.3162.1196.0230.3
DDS, EBITDALowest40.7153.7167.3197.5
DDS, EBITDA Margin (in %)Number of Estimates5999
DDS, EBITDA Margin (in %)Highest39.036.937.237.8
DDS, EBITDA Margin (in %)Consensus (Mean)37.137.935.834.935.836.5
DDS, EBITDA Margin (in %)Median35.934.736.137.0
DDS, EBITDA Margin (in %)Lowest33.133.133.233.5
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.